Nursing Elites

1. A client with myasthenia gravis is receiving pyridostigmine (Mestinon). The nurse should monitor the client for which of the following side effects?

• A. Constipation
• B. Hypertension
• C. Muscle weakness
• D. Bradycardia

Correct answer: D

Rationale: The correct answer is D: Bradycardia. Pyridostigmine, a cholinesterase inhibitor used in myasthenia gravis, can lead to bradycardia as a side effect. Choice A, constipation, is not a common side effect of pyridostigmine. Choice B, hypertension, is unlikely as pyridostigmine is more likely to cause hypotension. Choice C, muscle weakness, is actually a symptom of myasthenia gravis itself and not a side effect of pyridostigmine.

2. Which of these tests with frequency would the nurse expect to monitor for the evaluation of clients with poor glycemic control in persons aged 18 and older?

• A. A glycosylated hemoglobin (A1c) should be performed during an initial assessment and during follow-up assessments, which should occur at no longer than 3-month intervals
• B. A glycosylated hemoglobin should be obtained at least twice a year
• C. A fasting glucose and a glycosylated hemoglobin should be obtained at 3-month intervals after the initial assessment
• D. A glucose tolerance test, a fasting glucose, and a glycosylated hemoglobin should be obtained at 6-month intervals after the initial assessment

Correct answer: A

Rationale: Glycosylated hemoglobin (A1c) testing every 3 months is recommended for clients with poor glycemic control to monitor their average blood sugar levels and adjust treatment as necessary. Choice A is correct as it aligns with the guideline of performing A1c testing every 3 months. Choice B is incorrect because testing at least twice a year may not provide adequate monitoring for clients with poor glycemic control. Choice C is incorrect as it only mentions testing at 3-month intervals without specifying the importance of A1c testing. Choice D is incorrect as it includes unnecessary tests like glucose tolerance test and does not emphasize the importance of more frequent A1c monitoring for clients with poor glycemic control.

3. Which of the following strategies is most effective in promoting breastfeeding in a community?

• A. Providing formula samples
• B. Offering breastfeeding education and support
• C. Encouraging early weaning
• D. Promoting bottle feeding

Correct answer: B

Rationale: The most effective strategy in promoting breastfeeding in a community is offering breastfeeding education and support. This helps mothers learn about the benefits of breastfeeding, gain confidence in their ability to breastfeed, and receive necessary support to overcome challenges. Providing formula samples (Choice A) can undermine breastfeeding efforts by promoting formula feeding over breastfeeding. Encouraging early weaning (Choice C) goes against the recommendation of exclusive breastfeeding for the first six months of life. Promoting bottle feeding (Choice D) can deter mothers from initiating or continuing breastfeeding, leading to decreased breastfeeding rates.

4. When designing a community health project based on a report provided by the World Health Organization that describes healthcare problems in the United States, which healthcare issue should the nurse prioritize the highest when planning the project?

• A. Overuse of diagnostic technology.
• B. Government-based health insurance.
• C. The neonatal and infant mortality rates.
• D. Number of people without access to health care.

Correct answer: C

Rationale: The neonatal and infant mortality rates should be given the highest priority when planning the project because they are critical indicators of the overall health and healthcare system's effectiveness. High neonatal and infant mortality rates signify underlying issues in prenatal care, access to healthcare services, and quality of care for newborns and infants. Choice A, overuse of diagnostic technology, though important, may not be as critical as addressing neonatal and infant mortality rates. Choice B, government-based health insurance, is significant but may not directly impact neonatal and infant mortality rates. Choice D, the number of people without access to healthcare, is a crucial issue, but addressing neonatal and infant mortality rates should take precedence due to their immediate impact on the health and well-being of the most vulnerable population.

5. All of the following are objectives of FHSIS EXCEPT:

• A. To complete the clinical picture of chronic diseases and describe their natural history
• B. To provide a standardized, facility-level database that can be accessed for more in-depth studies
• C. To minimize recording and reporting burden, allowing more time for patient care and promotive activities
• D. To ensure that data reported are useful and accurate and are disseminated in a timely and easy-to-use fashion

Correct answer: A

Rationale: The correct answer is A. Completing the clinical picture of chronic diseases and describing their natural history is not an objective of FHSIS. The objectives of FHSIS include providing a standardized, facility-level database for more in-depth studies (B), minimizing recording and reporting burden to allow more time for patient care and promotive activities (C), and ensuring that reported data are useful, accurate, and disseminated in a timely and easy-to-use manner (D). Therefore, A is the exception among the listed objectives.

Similar Questions